Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inhibition of CD26 in human cord blood CD34+ cells enhances their engraftment of nonobese diabetic/severe combined immunodeficiency mice.

Stem cells and development - 1 Jun 2007

Campbell Timothy B, Hangoc Giao, Liu Ying, Pollok Karen, Broxmeyer Hal E

Abstract excerpt

CD26, a surface serine dipeptidylpeptidase IV (DPPIV) expressed on different cell types, cleaves the amino-terminal dipeptide from some chemokines, including stromal-derived factor-1 (SDF-1/CXCL12). SDF-1/CXCL12 plays important roles in hematopoietic stem cell (HSC) homing, engraftment, and mobil...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD34
Share to Dipeptidyl Peptidase 4
Share to Fetal Blood

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mice, Inbred NOD

Share to Mice, SCID

Share to Oligopeptides

Share to Stem Cell Transplantation

Share to Transplantation, Heterologous

Source

Identifiers

PMID: 17610364
DOI: 10.1089/scd.2007.9995

Genes

CXCL12

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17610364-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Inhibition of CD26 in human cord blood CD34+ cells enhances their engraftment of nonobese diabetic/severe combined immunodeficiency mice.PMID 17610364Read ↗

CD26 Inhibition on CD34 <sup>+</sup> or Lineage <sup>−</sup> Human Umbilical Cord Blood Donor Hematopoietic Stem Cells/Hematopoietic Progenitor Cells Improves Long-Term Engraftment into NOD/SCID/Beta2 <sup>null</sup> Immunodeficient MiceSemantic proximity Read ↗

Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemiaSemantic proximity Read ↗

Differential long-term and multilineage engraftment potential from subfractions of human CD34 + cord blood cells transplanted into NOD/SCID miceSemantic proximity Read ↗

SCID-repopulating cell activity of human cord blood-derived CD34- cells assured by intra-bone marrow injectionSemantic proximity Read ↗

DPPIV (CD26) as a novel stem cell marker in Ph+ chronic myeloid leukaemiaSemantic proximity Read ↗

Phenotypic and functional reversal within the early human hematopoietic compartment.Semantic proximity Read ↗

Cord blood CD34+ cells cultured with FLT3L, stem cell factor, interleukin-6, and IL-3 produce CD11c+CD1a-/c- myeloid dendritic cells.Semantic proximity Read ↗

Apheresis-related enrichment of CD26++ T lymphocytes: phenotypic characterization and correlation with unfavorable outcome in autologous hematopoietic progenitor cell transplantation.Semantic proximity Read ↗

The late dividing population of gamma-retroviral vector transduced human mobilized peripheral blood progenitor cells contributes most to gene-marked cell engraftment in nonobese diabetic/severe combined immunodeficient mice.Semantic proximity Read ↗

Quantitative Analysis Reveals Expansion of Human Hematopoietic Repopulating Cells After Short-term Ex Vivo CultureSemantic proximity Read ↗

Human CD26 expression in transgenic mice affects murine T-cell populations and modifies their subset distribution.Semantic proximity Read ↗

Restoration of Human B-cell Differentiation Into NOD-SCID Mice Engrafted With Gene-corrected CD34+ Cells Isolated From Artemis or RAG1-deficient PatientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.